Summary Box: Amylin sues partner Eli Lilly and Co.
Seattle Post Intelligencer
AP, THE COMPLAINT: Amylin Pharmaceuticals Inc. said Monday it filed a lawsuit against Eli Lilly and Co., accusing the larger drugmaker of breaking their commercialization deal for diabetes drugs by teaming with the German company Boehringer Ingelheim …
Lilly Provides Statement in Response to Amylin Lawsuit
Amylin Sues Eli Lilly, Arguing Breach of Contract in Marketing Rival Diabetes Drug
View full post on Health – Google News